(Q42629163)

4 November 2017

title

Risk factors for progressive visual field loss in primary open angle glaucoma (English)

1 reference

4 November 2017

Spry PG

1

1 reference

4 November 2017

Sparrow JM

series ordinal

2

1 reference

4 November 2017

Diamond JP

series ordinal

3

1 reference

4 November 2017

Harris HS

series ordinal

4

1 reference

4 November 2017

publication date

1 June 2005

1 reference

4 November 2017

1 reference

4 November 2017

volume

19

1 reference

4 November 2017

issue

6

1 reference

4 November 2017

page(s)

643-651

1 reference

Multivariate Analysis of the Risk of Glaucomatous Visual Field Loss

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Prevalence of glaucoma. The Beaver Dam Eye Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Risk factors for the development of glaucomatous visual field loss in ocular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Risk factors for progression of visual field abnormalities in normal-tension glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Epidemiological aids to clinical decision making in primary open angle glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Risk factors for visual field damage progression in normal-tension glaucoma eyes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Clinical factors influencing the visual prognosis of the fellow eyes of normal tension glaucoma patients with unilateral field loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Comparison of visual field progression in patients with normal pressure glaucoma between eyes with and without visual field loss that threatens fixation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Clinical factors associated with progression of glaucomatous optic disc damage in treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Serial examination of the normal visual field using Octopus automated projection perimetry. Evidence for a learning effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Chronic open-angle glaucoma and ocular hypertension. An epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Disc hemorrhages in the glaucomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

The African Caribbean Eye Survey: risk factors for glaucoma in a sample of African Caribbean people living in London

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Prevalence of glaucoma in the west of Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Elastosis of the lamina cribrosa in glaucomatous optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

The optic nerve head in glaucoma: role of astrocytes in tissue remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Early Manifest Glaucoma Trial: design and baseline data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

The relationship between structural and functional alterations in glaucoma: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Glaucoma screening: the importance of combining test data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

Structural-Functional Relationships of the Optic Nerve in Glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

A case-control study of risk factors in open angle glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

7 January 2021

Factors associated with long-term progression or stability in primary open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

7 January 2021

Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

7 January 2021

Diabetes mellitus and primary open-angle glaucoma. The XXVII Edward Jackson Memorial Lecture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

7 January 2021

Open angle glaucoma, ocular hypertension, low-tension glaucoma, and refraction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

7 January 2021

Effect of myopia on prognosis in treated primary open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

7 January 2021

Intraocular pressure in diabetic persons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

7 January 2021

Response of blood flow to warm and cold in normal and low-tension glaucoma patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

7 January 2021

The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven-year results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

7 January 2021

The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

7 January 2021

Changes in the extracellular matrix of the human optic nerve head in primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701605

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6701605

1 reference

Dimensions Publication ID

4 November 2017

1033528167

0 references

1 reference